Nuvalent Stock Buy Hold or Sell Recommendation
| NUVL Stock | USD 75.84 0.15 0.20% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Nuvalent is 'Hold'. The recommendation algorithm takes into account all of Nuvalent's available fundamental, technical, and predictive indicators you will find on this site.
Check out Nuvalent Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide. Note, we conduct extensive research on individual companies such as Nuvalent and provide practical buy, sell, or hold advice based on investors' constraints. Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Nuvalent |
Execute Nuvalent Buy or Sell Advice
The Nuvalent recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nuvalent. Macroaxis does not own or have any residual interests in Nuvalent or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nuvalent's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Nuvalent Trading Alerts and Improvement Suggestions
| Nuvalent generated a negative expected return over the last 90 days | |
| Net Loss for the year was (126.22 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nuvalent currently holds about 256.96 M in cash with (99.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.31. | |
| Nuvalent has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Nuvalents SWOT analysis biotech stock shows promise amid clinical progress |
Nuvalent Returns Distribution Density
The distribution of Nuvalent's historical returns is an attempt to chart the uncertainty of Nuvalent's future price movements. The chart of the probability distribution of Nuvalent daily returns describes the distribution of returns around its average expected value. We use Nuvalent price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nuvalent returns is essential to provide solid investment advice for Nuvalent.
| Mean Return | -0.44 | Value At Risk | -5.28 | Potential Upside | 2.60 | Standard Deviation | 2.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nuvalent historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nuvalent Stock Institutional Investors
| Shares | T. Rowe Price Associates, Inc. | 2024-09-30 | 1.1 M | Wellington Management Company Llp | 2024-09-30 | 1 M | Commodore Capital Lp | 2024-09-30 | 940 K | Driehaus Capital Management Llc | 2024-09-30 | 864 K | Geode Capital Management, Llc | 2024-09-30 | 855.6 K | Fred Alger Management, Llc | 2024-09-30 | 627.7 K | Pictet Asset Manangement Sa | 2024-09-30 | 621.1 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 471.7 K | Rock Springs Capital Management Lp | 2024-09-30 | 430 K | Deerfield Management Co | 2024-09-30 | 20 M | Fmr Inc | 2024-09-30 | 9.7 M |
Nuvalent Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nuvalent or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nuvalent's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nuvalent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 0.65 | |
σ | Overall volatility | 2.53 | |
Ir | Information ratio | -0.19 |
Nuvalent Volatility Alert
Nuvalent exhibits very low volatility with skewness of -0.64 and kurtosis of 2.21. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nuvalent's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nuvalent's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nuvalent Fundamentals Vs Peers
Comparing Nuvalent's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nuvalent's direct or indirect competition across all of the common fundamentals between Nuvalent and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nuvalent or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nuvalent's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nuvalent by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nuvalent to competition |
| Fundamentals | Nuvalent | Peer Average |
| Return On Equity | -0.3 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Current Valuation | 4.23 B | 16.62 B |
| Shares Outstanding | 65.62 M | 571.82 M |
| Shares Owned By Insiders | 2.80 % | 10.09 % |
| Shares Owned By Institutions | 97.20 % | 39.21 % |
| Number Of Shares Shorted | 5.69 M | 4.71 M |
| Price To Earning | (0.06) X | 28.72 X |
| Price To Book | 4.82 X | 9.51 X |
| EBITDA | (126.22 M) | 3.9 B |
| Net Income | (126.22 M) | 570.98 M |
| Cash And Equivalents | 256.96 M | 2.7 B |
| Cash Per Share | 5.31 X | 5.01 X |
| Total Debt | 31.82 M | 5.32 B |
| Debt To Equity | 2.81 % | 48.70 % |
| Current Ratio | 25.79 X | 2.16 X |
| Book Value Per Share | 15.81 X | 1.93 K |
| Cash Flow From Operations | (99.74 M) | 971.22 M |
| Short Ratio | 12.17 X | 4.00 X |
| Earnings Per Share | (3.49) X | 3.12 X |
| Target Price | 115.08 | |
| Number Of Employees | 127 | 18.84 K |
| Beta | 1.33 | -0.15 |
| Market Capitalization | 5.4 B | 19.03 B |
| Total Asset | 732.38 M | 29.47 B |
| Retained Earnings | (286.3 M) | 9.33 B |
| Working Capital | 694.66 M | 1.48 B |
| Current Liabilities | 5.46 M | 7.9 B |
| Net Asset | 732.38 M |
Note: Disposition of 2513 shares by Darlene Noci of Nuvalent at 88.79 subject to Rule 16b-3 [view details]
Nuvalent Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nuvalent . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nuvalent Buy or Sell Advice
When is the right time to buy or sell Nuvalent? Buying financial instruments such as Nuvalent Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nuvalent in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long Short Funds Thematic Idea Now
Long Short Funds
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Nuvalent Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.